Industry
Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Search
24 results for “als”
News
Cannabis-Based Drug Receives First European Market Approvals for Chronic Back Pain
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
Science
THC Linked to Creation of False Memories and Difficulty With Memory Tasks
People who consumed THC were more likely to recall words that were never shown to them.
Industry
113 Botanicals Launches £2m Raise to Bring Controlled-Release Cannabis Capsule to UK Patients
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
News
Releaf’s Landmark Survey Reveals “Transformative” Results for UK Patients
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still […]
News
Cannabis Health and MCCS to Bring “Vital” Clinician-Led Educational Event to UK Healthcare Professionals
Cannabis Health has partnered with experts at the Medical Cannabis Clinicians Society to host its first event for healthcare professionals.
News
Cannabis Health Launches ‘Landmark’ Symposium for UK Healthcare Professionals
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year.
Insight
The Talent Crunch: Where Will the Next 500 Medical Cannabis Professionals Come From?
Dr Sue Clenton, Medical Director at Releaf explores the role that clinics can play in recruiting and training the next generation of medical cannabis professionals.
Health
Endometriosis Patients Say Cannabis is “More Effective” Than Pharmaceuticals
But over half were concerned about the negative impact of stigma associated with cannabis.
News
Spain’s ‘Feeble’ Medical Cannabis Proposals Disappointing for Patients
Via Business of Cannabis Spain’s long-awaited medical cannabis program has finally taken a step forward as a draft of a Royal Decree has been sent to the European Union for […]
Industry
Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major […]
News
French Health Officials Recommended Medical Cannabis Framework in 2023, Report Reveals
In a report from November 2023, France’s Directorate General of Health (DGS) recommended the roll out of a temporary regulatory framework.
Epilepsy
UCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For
Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy.
Health
Anxiety and PTSD most common reasons for medical cannabis use among under 21s, reveals US study
A new study is one of the first to examine medical cannabis use among those under the age of 21 in the United States.
Industry
113 Botanicals and University of Sussex to bring controlled-release cannabis capsule and patches to UK
Scientists at 113 Botanicals and the University of Sussex are developing new formulations for cannabis-based medicines.
News
EU signals increasing shift in attitude towards cannabis reform
As reported by Business of Cannabis The European Commission (EC) last week partially approved a new ‘European Citizens Initiative’ focused on cannabis reform, in a move marking an increasing […]
Science
New study reveals why cannabis causes the ‘munchies’
The findings could pave the way for new treatments for appetite disorders experienced by cancer patients, anorexia and obesity.
News
US federal health officials acknowledge ‘accepted medical use’ of cannabis
The HHS has released documents confirming its recommendation that cannabis be rescheduled as a lower risk drug.
Health
Survey finds support for medical cannabis among UK health professionals
65% of respondents said they thought medical cannabis should be available on the NHS.
News
Israeli health officials to extend medical cannabis licences amid Gaza conflict
The Ministry of Health has taken steps to ensure cannabis patients can continue to access the treatment.
News
Top US health officials recommend rescheduling cannabis
The US Department of Health and Human Services has recommended that cannabis be classed as a lower risk drug. What does this mean for research, industry and consumers?
News
Report reveals countries leading the way in cannabis-related clinical trials
The UK saw the second highest number of clinical trials on cannabinoids in the last decade, the majority linked to GW Pharmaceuticals.
Science
Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure
Catch up on some of the latest cannabis science.
News
Cannabis-in-brief: First ‘victory’ for medical cannabis in Ukraine, Scotland’s bold approach to drugs and pain comes out top in trials
Your weekly debrief of the latest cannabis news.